DAMORA THERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-8.0M | $-8.0M | — | — |
| Jun 2020 | $-7.1M | $-7.1M | — | — |
| Sep 2020 | $-8.6M | $-8.6M | — | — |
| Dec 2020 | $-14.5M | $-14.5M | — | — |
| Mar 2021 | $-14.2M | $-14.2M | $65.0K | $1.0M |
| Jun 2021 | $-11.2M | $-11.3M | $115.0K | $987.0K |
| Sep 2021 | $-9.2M | $-9.2M | $47.0K | $1.2M |
| Dec 2021 | $-17.8M | $-17.8M | $-4.0K | $1.2M |
| Mar 2022 | $-6.8M | $-6.8M | $43.0K | $1.4M |
| Jun 2022 | $-14.8M | $-14.8M | $-26.0K | $1.4M |
| Sep 2022 | $-9.8M | $-10.0M | $138.0K | $1.4M |
| Dec 2022 | $-11.4M | $-11.5M | $41.0K | $1.3M |
| Mar 2023 | $-9.1M | $-9.1M | — | $1.4M |
| Jun 2023 | $-7.8M | $-7.8M | — | $1.4M |
| Sep 2023 | $-8.5M | $-8.5M | — | $1.5M |
| Dec 2023 | $-11.5M | $-11.5M | — | $1.1M |
| Mar 2024 | $-5.9M | $-5.9M | — | $1.4M |
| Jun 2024 | $-4.1M | $-4.1M | — | $891.0K |
| Sep 2024 | $-3.7M | $-3.7M | — | $681.0K |
| Dec 2024 | $-4.9M | $-4.9M | — | $308.0K |
| Mar 2025 | $-2.4M | $-2.4M | — | $179.0K |
| Jun 2025 | $-2.2M | $-2.2M | — | $172.0K |
| Sep 2025 | $-2.6M | $-2.6M | — | $164.0K |
| Dec 2025 | $566.0K | $566.0K | — | $483.0K |
| Mar 2026 | $-20.6M | $-20.6M | — | $3.1M |
| Jun 2026 | $-21.9M | $-21.9M | — | $6.1M |